Full-Time

Technical Operations Senior Engineer

Posted on 5/12/2026

Cardinal Health

Cardinal Health

Distributes pharmaceuticals and medical products globally

Compensation Overview

$68.5k - $97.8k/yr

Company Does Not Provide H1B Sponsorship

Indianapolis, IN, USA

In Person

Category
Biology & Biotech (1)
Required Skills
Risk Management
Data Analysis
Responsibilities
  • Applies comprehensive knowledge and a thorough understanding of concepts, principles, and technical capabilities to perform varied tasks and projects related to radiopharmaceutical processes.
  • Leads the creation, optimization, and documentation of new and existing operational processes for radiopharmaceuticals, ensuring alignment with ISO 13485 and 21 CFR 820 Quality System Regulationss
  • Oversees and executes the Change Control process for radiopharmaceutical operations, ensuring all proposed changes to processes, equipment, or materials are properly documented, assessed, approved, and implemented in compliance with regulatory requirements.
  • Serves as the primary Subject Matter Expert (SME) for all process-related questions, providing guidance and training to operations teams and cross-functional partners.
  • Actively assists operations in troubleshooting process issues, implementing process changes, and ensuring consistent execution of established procedures.
  • Involves in continuous improvement activities, identifying opportunities for process enhancements that increase efficiency, reduce waste, and improve product quality within radiopharmaceutical operations.
  • Identifies and implements data analysis to monitor process performance, ensure finished goods meet standards and specifications, and drives necessary changes to operational processes.
  • Supports Operations, Quality Control, Quality Assurance and Program Management teams by providing process expertise and ensuring process documentation supports compliance.
  • Performs activities related to Risk Management Plan, Risk Assessments with a focus on process-related risks in radiopharmaceutical production such as Master Batch Records and Master Packaging Records.
  • May contribute to the development of policies and procedures directly impacting radiopharmaceutical operations and process control.
  • Develops innovative technical solutions to a wide range of difficult process problems encountered in radiopharmaceutical manufacturing and support. Solutions are consistent with organization objectives.
  • Completes tasks independently after receiving general guidance on new projects or operational challenges.
Desired Qualifications
  • 2-6 years of experience, preferred
  • Bachelor's, Masters, preferred

Cardinal Health distributes pharmaceuticals and manufactures medical and laboratory products for hospitals, clinics, and pharmacies worldwide. The company operates a global logistics network to deliver supplies while providing data tools that help healthcare facilities track inventory and improve operational efficiency. Unlike many niche suppliers, Cardinal Health combines 50 years of experience with a massive scale that covers both the physical supply chain and the software needed to manage it. Its goal is to streamline the healthcare supply chain to ensure providers have reliable access to essential products while reducing costs and improving patient care.

Company Size

N/A

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • Majority stake in GI Alliance in November 2024 accelerates gastroenterology growth.
  • Acquired Advanced Diabetes Supply Group in November 2024 boosts at-Home Solutions.
  • Added Solaris Health urology MSO in August 2025 to Specialty Alliance platform.

What critics are saying

  • McKesson erodes specialty share with superior pharmacy analytics within 12-24 months.
  • Cencora undercuts generics pricing, squeezing margins in 6-12 months.
  • DEA quotas cut $500M opioid revenue comprising 20% sales in 3-6 months.

What makes Cardinal Health unique

  • Acquired Specialty Networks in January 2024 for multi-specialty GPOs in urology and gastroenterology.
  • Launched Kendall DL™ Multi System in June 2025 for continuous vital signs monitoring.
  • Expanded Actinium-225 production in April 2026 for novel cancer therapies.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Cardinal Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Short- and Long-term Disability Coverage

Paid Parental Leave

Wellness Program

Company News

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

intelligence360
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...

PR Newswire
Jan 10th, 2022
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

/PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global...